e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Exacerbations and COPD and rehabilitation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Low hematocrit as predictor of exacerbation frequency in COPD patients
R. Ferrari, S. Tanni, M. Faganello, L. Caram, R. Amaral, I. Godoy (Botucatu, Marília, Brazil)
Source:
Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Session:
Exacerbations and COPD and rehabilitation
Session type:
Thematic Poster Session
Number:
4103
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Ferrari, S. Tanni, M. Faganello, L. Caram, R. Amaral, I. Godoy (Botucatu, Marília, Brazil). Low hematocrit as predictor of exacerbation frequency in COPD patients. Eur Respir J 2010; 36: Suppl. 54, 4103
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Variability in exacerbation frequency in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 264s
Year: 2002
Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Determinants of exacerbation rate in patients with stable COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 661s
Year: 2004
Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007
CRP as predictor as predictor for late treatment failure in hospitalised patients with AECOPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Karnofsky index as predictor of exacerbations in moderate and severe COPD patients
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Cough rate may predict disease severity in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 536s
Year: 2004
Physical status and dependence levels in patients with COPD exacerbation
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014
Haemoglobin level and its clinical impact in a cohort of patients with COPD
Source: Eur Respir J 2007; 29: 923-929
Year: 2007
Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Under reporting acute exacerbation in patient with COPD: incidence and predictors?
Source: Eur Respir J 2006; 28: Suppl. 50, 175s
Year: 2006
Early occurrence of any COPD exacerbation predicts further higher risk of moderate/severe exacerbations regardless of recording tool: the FLAME study
Source: International Congress 2017 – Management of COPD
Year: 2017
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Predictors of poor outcome in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) receiving noninvasive positive pressure ventilation (NPPV
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015
Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD
Source: Eur Respir J, 50 (5) 1701162; 10.1183/13993003.01162-2017
Year: 2017
Influence of statin therapy on exacerbation frequency in patients with COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept